IPL & Light Therapies
In 1998 after 12 years extensive research and armed with the rights to the patented Paterson Photodynamic Therapy lamp for worldwide distribution, Cancer Research UK (the largest charity in the UK dedicated to Cancer Research) and the University of Manchester formed Phototherapeutics Ltd (PTL) with the mission of bringing effective, inexpensive and clinically proven cancer treatments to the healthcare market.
Further research revealed that PDT delivered on a matrix of narrow beam light emitting diodes (LED) could be used for a much broader range of conditions and as these treatments area non-surgical, laser-free they could effectively and safely be administered by skincare aesthetic practitioners and as such Omnilux was created to service both the medical and skincare industries.
What is Omnilux blue
Omnilux blue™ transmits blue light (415nm) for the treatment of acne vulgaris and sun damage. Omnilux blue is successfully used to activate coproporhyrin III present in the P.acnes bacteria. Its versatility also allows it to be used to activate the photosensitizer 5-Aminolevulinic acid in the treatment of superficial actinic keratosis.
How does Omnilux blue work?
Omnilux delivers pure light optimised to deliver the correct wavelength and dose for maximum activation of the target cells. Omnilux allows us to provide "Combination Phototherapy" in which we alternate between the anti-bacterial and anti-inflammatory activity of Omnilux blue and with Omnilux revive Photodynamic Light Therapy systems. Omnilux revive delivers a totally pure, visible red light that stimulates the deeper skin tissue by activating molecules that absorb this light, it leads to improved skin tone, texture and skin firming for a more radiant and youthful appearance. It works with the body's own natural processes to counteract the effects of aging while increasing blood flow to cells resulting in greater tissue oxygenation and detoxification.
Only by delivering the right wavelength in sequence can optimum results be seen. Activation of coproporphyrin III creates intracellular singlet oxygen - inducing bacterial death. This reduces the bacterial colonisation of the sebaceous gland, returning the gland’s abnormally high level of sebum to normal and reducing the production of proinflammatory cytokines.
Simultaneously, Omnilux blue induces anti-inflammatory cytokines, stimulating specific immunoregulatory pathways.